US Oncology gets $120 million three-year revolver via four banks

By Sara Rosenberg

New York, Aug. 28 - US Oncology Holdings Inc. closed on a $120 million senior secured revolving credit facility due Aug. 31, 2012, according to an 8-K filed with the Securities and Exchange Commission on Friday.

Deutsche Bank, JPMorgan, Morgan Stanley and Wells Fargo acted as the lead arrangers and bookrunners on the deal that was completed on Aug. 26, with Deutsche the administrative agent.

Pricing on the revolver is Libor plus 450 basis points.

Covenants include a total leverage ratio requirement.

Proceed were used to refinance an existing credit facility.

US Oncology is a The Woodlands, Texas-based cancer services company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.